Effects of long-term treatment with low-dose pravastatin on biliary lipid and bile acid composition in patients with nonfamilial hyperlipoproteinemia-Reference-Cited by-同舟云学术

Effects of long-term treatment with low-dose pravastatin on biliary lipid and bile acid composition in patients with nonfamilial hyperlipoproteinemia

Published:1995-11 Issue:11 Volume:44 Page:1410-1412
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Tazuma Susumu,Takizawa Itsuo,Kunita Tetsuro,Mizuno Toshiyuki,Watanabe Tetsuhiko,Teramen Kazushi,Horikawa Kazuhiko,Ochi Hidenori,Yamashita Yoshifumi,Aihara Naoki,Sasaki Masatoshi,Hirano Naomichi,Miura Hiroyuki,Hatsushika Sumie,Ohya Toshihide,Kajiyama Goro,Itoh Katsuhide

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference19 articles.

1. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol;Reihner;N Engl J Med,1990

2. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: Relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment;Ahlberg;J Lipid Res,1981

3. Clofibrate and gallstones;Cooper;Lancet,1975

4. Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man;Grundy;J Lipid Res,1981

5. Gallbladder diseases as a side effect of drugs;N Engl J Med,1977

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term administration of a Niemann-Pick C1-like 1 inhibitor, ezetimibe, does not worsen bile lithogenicity in dyslipidemic patients with hepatobiliary diseases;Journal of Hepato-Biliary-Pancreatic Sciences;2016-01-25

2. Statin use and risk of gallstone disease: A meta-analysis;Hepatology Research;2014-11-12

3. Nutritional factors (nutritional aspects) in biliary disorders: Bile acid and lipid metabolism in gallstone diseases and pancreaticobiliary maljunction;Journal of Gastroenterology and Hepatology;2013-11-19

4. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol;European Journal of Clinical Investigation;2013-02-19

5. Lipid Lowering Drugs and Gallstones: A Therapeutic Option?;Current Pharmaceutical Design;2011-11-01